Survival prolongation by rationale innovative genomics (SPRING): An international WIN consortium phase I study exploring safety and efficacy of avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2019-10, Vol.30, p.v648 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | v648 |
| container_title | Annals of oncology |
| container_volume | 30 |
| creator | Solomon, B. Callejo, A. Bar, J. Berchem, G. Bazhenova, L. Saintigny, P. Raymond, E. Girard, N. Sulaiman, R. Bresson, C. Wunder, F. Lee, J.J. Raynaud, J. Rubin, E. Young, B. Lazar, V. Felip, E. Onn, A. Leyland-Jones, B. Kurzrock, R. |
| description | |
| doi_str_mv | 10.1093/annonc/mdz260.096 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdz260_096</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdz260_096</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1336-c786963b2a3dcab933b4717f2598e02a9b1721b01ce6cc052d14eabb4fa469b63</originalsourceid><addsrcrecordid>eNotUU1v1DAQDRJIlMIdbnNsJdLa8W5Sc6tWUFZaLYgFcYzGE2dr5NiRnYSmv77ej4vHM_PmzTy9LPvE2Q1nUtyic97Rbdc8FyW7YbJ8nV0wWYi8WorF2-xdjP8YY6Us5MWrj7sxTGZCC33w1rs9DsY7UDOE4w-tBpP4ppRNGvba-c5QhKvdz1_r7cP1F7h3CTDo4M54-LveAnkXfRjM2EH_iFHDGuIwNjPop976YNweIrZ6mAFdA7ptDSHN4FvASduxQ_UZerTKkyFrUnKA4ZMZjDMq7QNsJnSkG0hS89ihtUA6PXZM1HRoBbja7lab1TX8N8Pj8cZ90pRGziKOnENAFymYfjiWyIegbULF99mbFm3UH87xMvvz7evv1fd88-Nhvbrf5MSFKHOq7kpZClWgaAiVFEItKl61xVLeaVagVLwquGKcdEnElkXDFxqVWrS4KKUqxWXGT7wUfIxBt3UfTIdhrjmrD3bWJzvrk511slO8AJzonxw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Survival prolongation by rationale innovative genomics (SPRING): An international WIN consortium phase I study exploring safety and efficacy of avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Solomon, B. ; Callejo, A. ; Bar, J. ; Berchem, G. ; Bazhenova, L. ; Saintigny, P. ; Raymond, E. ; Girard, N. ; Sulaiman, R. ; Bresson, C. ; Wunder, F. ; Lee, J.J. ; Raynaud, J. ; Rubin, E. ; Young, B. ; Lazar, V. ; Felip, E. ; Onn, A. ; Leyland-Jones, B. ; Kurzrock, R.</creator><creatorcontrib>Solomon, B. ; Callejo, A. ; Bar, J. ; Berchem, G. ; Bazhenova, L. ; Saintigny, P. ; Raymond, E. ; Girard, N. ; Sulaiman, R. ; Bresson, C. ; Wunder, F. ; Lee, J.J. ; Raynaud, J. ; Rubin, E. ; Young, B. ; Lazar, V. ; Felip, E. ; Onn, A. ; Leyland-Jones, B. ; Kurzrock, R.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdz260.096</identifier><language>eng</language><ispartof>Annals of oncology, 2019-10, Vol.30, p.v648</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1336-c786963b2a3dcab933b4717f2598e02a9b1721b01ce6cc052d14eabb4fa469b63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Solomon, B.</creatorcontrib><creatorcontrib>Callejo, A.</creatorcontrib><creatorcontrib>Bar, J.</creatorcontrib><creatorcontrib>Berchem, G.</creatorcontrib><creatorcontrib>Bazhenova, L.</creatorcontrib><creatorcontrib>Saintigny, P.</creatorcontrib><creatorcontrib>Raymond, E.</creatorcontrib><creatorcontrib>Girard, N.</creatorcontrib><creatorcontrib>Sulaiman, R.</creatorcontrib><creatorcontrib>Bresson, C.</creatorcontrib><creatorcontrib>Wunder, F.</creatorcontrib><creatorcontrib>Lee, J.J.</creatorcontrib><creatorcontrib>Raynaud, J.</creatorcontrib><creatorcontrib>Rubin, E.</creatorcontrib><creatorcontrib>Young, B.</creatorcontrib><creatorcontrib>Lazar, V.</creatorcontrib><creatorcontrib>Felip, E.</creatorcontrib><creatorcontrib>Onn, A.</creatorcontrib><creatorcontrib>Leyland-Jones, B.</creatorcontrib><creatorcontrib>Kurzrock, R.</creatorcontrib><title>Survival prolongation by rationale innovative genomics (SPRING): An international WIN consortium phase I study exploring safety and efficacy of avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNotUU1v1DAQDRJIlMIdbnNsJdLa8W5Sc6tWUFZaLYgFcYzGE2dr5NiRnYSmv77ej4vHM_PmzTy9LPvE2Q1nUtyic97Rbdc8FyW7YbJ8nV0wWYi8WorF2-xdjP8YY6Us5MWrj7sxTGZCC33w1rs9DsY7UDOE4w-tBpP4ppRNGvba-c5QhKvdz1_r7cP1F7h3CTDo4M54-LveAnkXfRjM2EH_iFHDGuIwNjPop976YNweIrZ6mAFdA7ptDSHN4FvASduxQ_UZerTKkyFrUnKA4ZMZjDMq7QNsJnSkG0hS89ihtUA6PXZM1HRoBbja7lab1TX8N8Pj8cZ90pRGziKOnENAFymYfjiWyIegbULF99mbFm3UH87xMvvz7evv1fd88-Nhvbrf5MSFKHOq7kpZClWgaAiVFEItKl61xVLeaVagVLwquGKcdEnElkXDFxqVWrS4KKUqxWXGT7wUfIxBt3UfTIdhrjmrD3bWJzvrk511slO8AJzonxw</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Solomon, B.</creator><creator>Callejo, A.</creator><creator>Bar, J.</creator><creator>Berchem, G.</creator><creator>Bazhenova, L.</creator><creator>Saintigny, P.</creator><creator>Raymond, E.</creator><creator>Girard, N.</creator><creator>Sulaiman, R.</creator><creator>Bresson, C.</creator><creator>Wunder, F.</creator><creator>Lee, J.J.</creator><creator>Raynaud, J.</creator><creator>Rubin, E.</creator><creator>Young, B.</creator><creator>Lazar, V.</creator><creator>Felip, E.</creator><creator>Onn, A.</creator><creator>Leyland-Jones, B.</creator><creator>Kurzrock, R.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201910</creationdate><title>Survival prolongation by rationale innovative genomics (SPRING): An international WIN consortium phase I study exploring safety and efficacy of avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates</title><author>Solomon, B. ; Callejo, A. ; Bar, J. ; Berchem, G. ; Bazhenova, L. ; Saintigny, P. ; Raymond, E. ; Girard, N. ; Sulaiman, R. ; Bresson, C. ; Wunder, F. ; Lee, J.J. ; Raynaud, J. ; Rubin, E. ; Young, B. ; Lazar, V. ; Felip, E. ; Onn, A. ; Leyland-Jones, B. ; Kurzrock, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1336-c786963b2a3dcab933b4717f2598e02a9b1721b01ce6cc052d14eabb4fa469b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Solomon, B.</creatorcontrib><creatorcontrib>Callejo, A.</creatorcontrib><creatorcontrib>Bar, J.</creatorcontrib><creatorcontrib>Berchem, G.</creatorcontrib><creatorcontrib>Bazhenova, L.</creatorcontrib><creatorcontrib>Saintigny, P.</creatorcontrib><creatorcontrib>Raymond, E.</creatorcontrib><creatorcontrib>Girard, N.</creatorcontrib><creatorcontrib>Sulaiman, R.</creatorcontrib><creatorcontrib>Bresson, C.</creatorcontrib><creatorcontrib>Wunder, F.</creatorcontrib><creatorcontrib>Lee, J.J.</creatorcontrib><creatorcontrib>Raynaud, J.</creatorcontrib><creatorcontrib>Rubin, E.</creatorcontrib><creatorcontrib>Young, B.</creatorcontrib><creatorcontrib>Lazar, V.</creatorcontrib><creatorcontrib>Felip, E.</creatorcontrib><creatorcontrib>Onn, A.</creatorcontrib><creatorcontrib>Leyland-Jones, B.</creatorcontrib><creatorcontrib>Kurzrock, R.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Solomon, B.</au><au>Callejo, A.</au><au>Bar, J.</au><au>Berchem, G.</au><au>Bazhenova, L.</au><au>Saintigny, P.</au><au>Raymond, E.</au><au>Girard, N.</au><au>Sulaiman, R.</au><au>Bresson, C.</au><au>Wunder, F.</au><au>Lee, J.J.</au><au>Raynaud, J.</au><au>Rubin, E.</au><au>Young, B.</au><au>Lazar, V.</au><au>Felip, E.</au><au>Onn, A.</au><au>Leyland-Jones, B.</au><au>Kurzrock, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Survival prolongation by rationale innovative genomics (SPRING): An international WIN consortium phase I study exploring safety and efficacy of avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates</atitle><jtitle>Annals of oncology</jtitle><date>2019-10</date><risdate>2019</risdate><volume>30</volume><spage>v648</spage><pages>v648-</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdz260.096</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2019-10, Vol.30, p.v648 |
| issn | 0923-7534 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdz260_096 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Survival prolongation by rationale innovative genomics (SPRING): An international WIN consortium phase I study exploring safety and efficacy of avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T19%3A10%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Survival%20prolongation%20by%20rationale%20innovative%20genomics%20(SPRING):%20An%20international%20WIN%20consortium%20phase%20I%20study%20exploring%20safety%20and%20efficacy%20of%20avelumab,%20palbociclib,%20and%20axitinib%20in%20advanced%20non-small%20cell%20lung%20cancer%20(NSCLC)%20with%20integrated%20genomic%20and%20transcriptomic%20correlates&rft.jtitle=Annals%20of%20oncology&rft.au=Solomon,%20B.&rft.date=2019-10&rft.volume=30&rft.spage=v648&rft.pages=v648-&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdz260.096&rft_dat=%3Ccrossref%3E10_1093_annonc_mdz260_096%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |